Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$314K Buy
8,718
+198
+2% +$8.19K 0.02% 621
2022
Q1
$417K Buy
8,520
+14
+0.2% +$709 0.03% 571
2021
Q4
$408K Buy
8,506
+48
+0.6% +$2.27K 0.02% 574
2021
Q3
$371K Sell
8,458
-21
-0.2% -$888 0.03% 565
2021
Q2
$372K Buy
8,479
+1,529
+22% +$71.8K 0.02% 589
2021
Q1
$318K Sell
6,950
-4
-0.1% -$168 0.02% 612
2020
Q4
$225K Buy
+6,954
New +$201K 0.02% 672
2020
Q1
Sell
-5,183
Closed -$202K 693
2019
Q4
$202K Buy
+5,183
New +$190K 0.02% 601

Other funds holding SNV

Advisor Partners's SNV Position: Q2 2022 in Review

Advisor Partners increased its Synovus (SNV) stake by 2.3% in Q2 2022, buying an estimated $8.19K and bringing the position to 8,718 shares worth $314K. The position accounts for 0.02% of the portfolio, ranked #621.

Advisor Partners first reported a position in SNV in Q4 2019 and has held it in 8 quarters since. The position peaked at $417K in Q1 2022. 417 funds tracked by Wall St. Rank hold SNV as of Q2 2022.

  • Advisor Partners held 8,718 shares of Synovus worth $314K as of Q2 2022.
  • Advisor Partners bought 198 Synovus shares in Q2 2022, an estimated $8.19K.
  • Synovus made up 0.02% of Advisor Partners's portfolio in Q2 2022, its #621 holding.
  • Advisor Partners first reported a position in Synovus in Q4 2019 and has held it in 8 quarters since.
  • Advisor Partners's Synovus position peaked at $417K in Q1 2022.
  • 417 funds tracked by Wall St. Rank held Synovus as of Q2 2022.

Based on Advisor Partners's 13F filing for Q2 2022, filed 11 Aug 2022.